GHK-Cu + BPC-157 + TB-500 (Glow blend)
The 2026 BPC-157 + TB-500 rat study provides partial-stack preclinical evidence only. It does not establish the efficacy, safety or interaction profile of the three-component blend after adding GHK-Cu.
Exact-combination evidence
Commercial/community blend; component evidence only
The 2026 BPC-157 + TB-500 rat study provides partial-stack preclinical evidence only. It does not establish the efficacy, safety or interaction profile of the three-component blend after adding GHK-Cu.
Human combination evidence
No direct controlled human trial of the three-component blend identified in current evidence set
Combination safety
No validated blend-specific safety framework
Component evidence and direct combination evidence are kept separate. Study doses or regimens, where mentioned, describe the cited research only and are not recommendations for personal use.